Clinical Trial Update: Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma [Phase 2]

View source ↗

Summary

Phase 2 trial of temozolomide in newly diagnosed anaplastic oligodendroglioma and mixed oligoastrocytoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Oligodendroglioma
• Oligoastrocytoma Mixed

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Oligoastrocytoma, Mixed, Anaplastic Oligodendroglioma | Phase 2 | Status: COMPLETED